JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathiesGina A. Montealegre Sanchez, Jonathan Janes, Jason Dare et al.|Journal of Clinical Investigation|2018Cited by 519
The liver diseases of lipodystrophy: The long-term effect of leptin treatmentElika Safar Zadeh, Phillip Görden, Andreea O. Lungu et al.|Journal of Hepatology|2013Cited by 165
Serum Proteomics of Insulin Resistance Disorders Distinguish MASLD From Lipodystrophy and Insulin Receptor DefectsMaria Mironova, Yaron Rotman, Brent S. Abel et al.|The Journal of Clinical Endocrinology & Metabolism|2025Cited by 3
Su1577 UNRAVELING MECHANISMS OF HEPATIC INVOLVEMENT IN DISORDERS WITH IMPAIRED INSULIN SIGNALING: A PROTEOMIC ANALYSIS.Maria Mironova, Rebecca J. Brown, Allison Wing et al.|Gastroenterology|2024Cited by 0